PT1889607E - Formulação líquida injectável de paracetamol - Google Patents

Formulação líquida injectável de paracetamol Download PDF

Info

Publication number
PT1889607E
PT1889607E PT07112327T PT07112327T PT1889607E PT 1889607 E PT1889607 E PT 1889607E PT 07112327 T PT07112327 T PT 07112327T PT 07112327 T PT07112327 T PT 07112327T PT 1889607 E PT1889607 E PT 1889607E
Authority
PT
Portugal
Prior art keywords
paracetamol
solution
injectable liquid
paracetamol formulation
liquid paracetamol
Prior art date
Application number
PT07112327T
Other languages
English (en)
Inventor
Faustino Huertas Munoz
Raul Fernandez Plagaro
Original Assignee
Genfarma Lab S L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38474429&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT1889607(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Genfarma Lab S L filed Critical Genfarma Lab S L
Publication of PT1889607E publication Critical patent/PT1889607E/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pain & Pain Management (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Detergent Compositions (AREA)
PT07112327T 2006-07-18 2007-07-12 Formulação líquida injectável de paracetamol PT1889607E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/ES2006/070108 WO2008009756A1 (es) 2006-07-18 2006-07-18 Formulación líquida inyectable de paracetamol

Publications (1)

Publication Number Publication Date
PT1889607E true PT1889607E (pt) 2009-07-20

Family

ID=38474429

Family Applications (1)

Application Number Title Priority Date Filing Date
PT07112327T PT1889607E (pt) 2006-07-18 2007-07-12 Formulação líquida injectável de paracetamol

Country Status (17)

Country Link
US (2) US9943479B2 (pt)
EP (2) EP1889607B1 (pt)
JP (1) JP4929352B2 (pt)
AT (1) ATE432690T1 (pt)
AU (2) AU2006346318B2 (pt)
CA (1) CA2628806C (pt)
CY (1) CY1110480T1 (pt)
DE (1) DE602007001215D1 (pt)
DK (1) DK1889607T3 (pt)
ES (1) ES2327286T3 (pt)
HR (1) HRP20090350T1 (pt)
MA (1) MA31346B1 (pt)
PL (1) PL1889607T3 (pt)
PT (1) PT1889607E (pt)
RU (1) RU2419421C2 (pt)
SI (1) SI1889607T1 (pt)
WO (1) WO2008009756A1 (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2926992B1 (fr) * 2008-02-06 2011-01-14 Moly Pharma Formulation d'une solution de paracetamol injectable,procede de preparation et de conditionnement d'une telle solution et dispositif de conditionnement d'une telle solution
EP2243477A1 (de) 2009-04-22 2010-10-27 Fresenius Kabi Deutschland GmbH Paracetamol zur parenteralen Verabreichung
US8404748B2 (en) * 2009-08-13 2013-03-26 Neogen N.V. Storage-stable formulation of paracetamol in aqueous solution
IN2012DN05192A (pt) * 2010-01-21 2015-10-23 Aprea Ab
ES2389760T3 (es) 2010-04-14 2012-10-31 B. Braun Melsungen Ag Composición de acetaminofeno
ES2414557B1 (es) 2012-01-16 2014-06-10 Novocat Farma, S.A. Composición acuosa de paracetamol para inyección
ITMI20121154A1 (it) * 2012-06-29 2013-12-30 Sint Sa Soluzione iniettabile di acetaminofene per la somministrazione spinale
ZA201300398B (en) * 2012-11-27 2013-09-25 Genfarma Laboratories S L Injectable liquid formulation of the combination of tramadol and paracetamol
US20140303254A1 (en) * 2013-04-08 2014-10-09 InnoPharma Licensing LLC Process Of Manufacturing A Stable, Ready To Use Infusion Bag For An Oxidation Sensitive Formulation
BR102014005885B1 (pt) * 2014-03-13 2021-04-13 Biotec Biológica Indústria Farmacêutica Ltda E.P.P Formulação farmacêutica líquida injetável estável de paracetamol em bolsa plástica pronta para uso
EP3171868B1 (en) * 2014-07-25 2020-09-30 Terumo Kabushiki Kaisha Packaged acetaminophen injection solution preparation
HUE053952T4 (hu) * 2016-02-05 2021-09-28 Innopharma Inc Eljárás oxidációra érzékeny készítményhez stabil, alkalmazásra kész infúziós tasak elõállítására

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4440815A (en) 1981-06-29 1984-04-03 Abbott Laboratories Clear, autoclavable plastic formulation for medical liquid containers
FR2751875B1 (fr) * 1996-08-05 1998-12-24 Scr Newpharm Nouvelles formulations liquides stables a base de paracetamol et leur mode de preparation
KR100226191B1 (ko) 1997-04-03 1999-10-15 구광시 음료용 플라스틱 병
DE69840028D1 (de) * 1997-10-23 2008-10-30 Morinaga Milk Industry Co Ltd Verfahren sowie vorrichtung zur kontiuierlichen hitzesterilisierung von fluessigkeiten
DK0916347T3 (da) * 1997-11-18 2003-04-22 Uni Pharma Kleon Tsetis A B E Farmaceutiske injicerbare opløsninger der indeholder paracetamol og kombinationer af paracetamol med andre aktive bestanddele
IT1301976B1 (it) 1998-07-31 2000-07-20 Angelini Ricerche Spa Composizione farmaceutica iniettabile a base di paracetamolo
FR2809619B1 (fr) * 2000-06-06 2004-09-24 Pharmatop Nouvelles formulations aqueuses de principes actifs sensibles a l'oxydation et leur procede d'obtention
DE10112325A1 (de) 2001-03-13 2002-10-02 Fresenius Kabi De Gmbh Lagerstabile Fertiginfusionslösungen des Paracetamols
ITMI20012135A1 (it) * 2001-10-16 2003-04-16 Bioren S A Soluzioni iniettabili pronte all'uso di paracetamolo
HUP0402549A3 (en) 2001-12-18 2006-01-30 Tseti Ioulia Parenteral composition of paracetamol
CA2487450C (en) * 2002-05-27 2009-09-22 Kyorin Pharmaceutical Co., Ltd. (2s)-2-ethylphenylpropanoic acid derivatives
AU2003251152A1 (en) * 2002-07-03 2004-01-23 Shannon Biotechnology Ltd Pharmaceutical formulations for preparing drink products
FR2851164B1 (fr) * 2003-02-14 2005-04-22 Xuan Tho Nguyen Formulation liquide injectable de paracetamol
FR2862872A1 (fr) 2003-12-02 2005-06-03 Palbian Snc Composition a l'etat aqueux pour l'application perfusable d'un principe actif, notamment pharmacologique tel que le paracetamol.
US20060292225A1 (en) 2005-06-24 2006-12-28 Felix Arthur M Water soluble analgesic formulations and methods for production

Also Published As

Publication number Publication date
DE602007001215D1 (de) 2009-07-16
MA31346B1 (fr) 2010-05-03
CA2628806C (en) 2012-08-21
US9943479B2 (en) 2018-04-17
PL1889607T3 (pl) 2009-10-30
US20090215903A1 (en) 2009-08-27
ATE432690T1 (de) 2009-06-15
AU2011201253A1 (en) 2011-04-07
SI1889607T1 (sl) 2009-10-31
EP2100596A2 (en) 2009-09-16
EP2100596A3 (en) 2010-04-28
ES2327286T3 (es) 2009-10-27
DK1889607T3 (da) 2009-07-27
HRP20090350T1 (en) 2009-08-31
RU2009105480A (ru) 2010-08-27
AU2006346318A1 (en) 2008-01-24
JP4929352B2 (ja) 2012-05-09
US20160199325A1 (en) 2016-07-14
JP2009543851A (ja) 2009-12-10
AU2011201253B2 (en) 2012-03-29
AU2006346318B2 (en) 2011-02-10
EP1889607B1 (en) 2009-06-03
RU2419421C2 (ru) 2011-05-27
CA2628806A1 (en) 2008-01-24
US9943492B2 (en) 2018-04-17
WO2008009756A1 (es) 2008-01-24
CY1110480T1 (el) 2015-04-29
EP1889607A1 (en) 2008-02-20

Similar Documents

Publication Publication Date Title
HRP20090350T1 (en) Injectable liquid paracetamol formulation
TW200605872A (en) Alcohol-metabolism enhancing composition and ingesta containing the same
WO2007089473A3 (en) Thickened fluid composition comprising chlorine dioxide
TW200633951A (en) Method for reducing cyclohexenone content of a cyclohexenone-containing organic mixture
CL2013002692A1 (es) Soluciones estabilizadas de acido hipohaloso y una cantidad estabilizadora de carbono inorganico disuelto; y metodo de preparacion de la misma.
FI3340966T3 (fi) Nopeavaikutteisia insuliinikoostumuksia
BRPI0706966A8 (pt) Composição para um efeito microbicida em um sistema de água, método para estabilizar cloro para ser utilizado como um biocida no tratamento de água em um sistema de processamento, e método para tratar um sistema de água de processamento de papel
DK2010014T3 (da) Solubilisater af konserveringsmidler og fremgangsmåde til fremstilling heraf
WO2005115416A3 (en) Method of treating with chlorine dioxide
EP2096440A4 (en) METHOD FOR STABILIZING -THROMBIN IN THROMBIN CONTAINING SOLUTION
ATE367167T1 (de) Aufbereitung von aldesleukin zur pharmazeutischen verwendung
EA200801606A1 (ru) Предварительно увлажненная антигололедная композиция со стабилизированной насыщенностью
IL161390A0 (en) Ready-to-use- paracetamol injection solutions containing propylene glycol as the only cosolvent
BRPI0513244A (pt) composto de clatrato, método para controlar a concentração de solução aquosa de ingrediente ativo quìmico agrìcola e formulação quìmica agrìcola
CN103499574A (zh) 铝离子检测试纸及其制备方法和使用方法
UA92218C2 (ru) Способ получения стабильного при хранении биодизельного топлива
BR112012018427A2 (pt) uso de composto, e, método para aumentar o ph de uma suspensão aquosa
DE602004007762D1 (de) Herbizide zusammensetzung und verwendung
Li Simultaneous determination of phthalate esters by micelle capillary electrophoresis
Su Mechanism of Hg (II) biosorption by saccharomyces cerevisiae
RS51179B (sr) Tečne injektabilne formulacije paracetamola
Tu et al. The construct of a neutral medium applicable electrochemiluminescent sensor based on the chemical modification of cysteine and luminol.
UA83157C2 (ru) Сорбент для извлечения ионов fe 2+ из водных растворов и физиологических жидкостей
ATE544826T1 (de) Tintenkonzentrat zur herstellung von inkjet- tinten
TH131039B (th) สารพาสำหรับตัวกระทำออกฤทธิ์ที่มีการปลดปล่อยแบบควบคุมชนิดใหม่